The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines
Open Access
- 25 April 2022
- journal article
- research article
- Published by Springer Nature in Oncology and Therapy
- Vol. 10 (2) , 377-388
Abstract
Introduction Irisin is a newly discovered myokine released from skeletal muscle during exercise. The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that play a key role in the metastatic process via degrading extracellular matrix. The aim of this study was to investigate the effect of irisin on expression of metastatic markers MMP2 and MMP9 and induced apoptosis in human prostate cancer cells. Methods In this study, we examined the effect of different concentrations of irisin on induced apoptosis and cell viability of two cell lines, LNCaP and DU-145, by using flow cytometry and MTT assay, respectively. The expression of MMP2 and MMP9 genes was also analyzed by real-time PCR after irisin treatment. Data were analyzed using the comparative cycle threshold 2−∆∆Ct method. Results Cell viability was reduced in both LNCaP and DU-145 cell lines at different concentrations of irisin. However, this decreased cell viability was strongly significant (p < 0.05) only at 5 and 10 nM concentrations of irisin in the LNCaP cell line. Furthermore, irisin could induce apoptosis in both cell lines at a concentration of 10 nM compared to 5 nM. Real-time PCR results also demonstrated a decreased expression in MMP2 and MMP9 genes in a concentration-dependent manner in both cell lines. Conclusion These results showed the anticancer effects of irisin on cell viability of both LNCaP and DU-145 cell lines and also on the expression of MMP2 and MMP9 genes occurred in a dose- and time-dependent manner.Keywords
This publication has 56 references indexed in Scilit:
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesisNature, 2012
- Evaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experienceCancer Management and Research, 2011
- Evaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experienceCancer Management and Research, 2011
- Biological role of matrix metalloproteinases: a critical balanceEuropean Respiratory Journal, 2010
- Unexpected evidence for active brown adipose tissue in adult humansAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCRLung Cancer, 2004
- Androgen deprivation therapy for prostate cancer: Current status and future prospectsThe Prostate, 2004
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Matrix metalloproteinasesEuropean Journal of Cancer, 2000
- Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lungPathology International, 1997